Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Antidepressant fluvoxamine can save COVID-19 patients, McMaster-led research shows
An inexpensive oral antidepressant can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University. McMaster researcher Ed . . .
Environmental racism: New study investigates whether Nova Scotia dump boosted cancer rates in nearby Black community
In the 1940s, the town of Shelburne, N.S., became home to a new garbage dump. Residential, industrial and medical waste from throughout eastern Shelburne County . . .
Opioid overdoses spiked during the COVID-19 pandemic, data from Pennsylvania show
Since the first diagnosed case of COVID-19 in the United States on Jan. 20, 2020, news about infection rates, deaths and pandemic-driven economic hardships has . . .
Discover how Our Research is making an Impact
